Cargando…
Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance
A benzene-poly-carboxylic acid complex with cis-diammineplatinum(II) dihydrocholride, BP-C1 is currently used in clinical trials in treating metastatic breast cancer. BP-C1 controls tumor growth with a few mild side-effects, improving quality of life. METHODS: The data consisted of prospectively col...
Autores principales: | Lindkær-Jensen, Steen, Larsen, Stig, Habib-Lindkær-Jensen, Nina, Fagertun, Hans E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364592/ https://www.ncbi.nlm.nih.gov/pubmed/25792808 http://dx.doi.org/10.2147/DDDT.S80451 |
Ejemplares similares
-
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
por: Larsen, Stig, et al.
Publicado: (2014) -
Benzene-Poly-Carboxylic Acid Complex, a Novel Anti-Cancer Agent Induces Apoptosis in Human Breast Cancer Cells
por: Fares, Fuad, et al.
Publicado: (2014) -
Distribution and Effect of Galanin on Gallbladder and Sphincter of Oddi Motility in the Pig
por: Harling, Henrik, et al.
Publicado: (1991) -
Suicide Gene Therapy in Liver Tumors
por: Jiao, Long R., et al.
Publicado: (2004) -
Sclerotherapy as a primary or salvage procedure for aneurysmal bone cysts: A single-center experience
por: Weber, Kolja Sebastian, et al.
Publicado: (2023)